Neogenomics Inc NEO:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
after hours iconAfter Hours: Last | 4:00 PM EDT
13.77UNCH (UNCH)
Volume
262,460
Close
13.77quote price arrow up+0.09 (+0.66%)
Volume
651,056
52 week range
11.03 - 21.22
Loading...
  • Open13.70
  • Day High14.09
  • Day Low13.62
  • Prev Close13.68
  • 52 Week High21.22
  • 52 Week High Date12/22/23
  • 52 Week Low11.03
  • 52 Week Low Date10/04/23

Key Stats

  • Market Cap1.758B
  • Shares Out127.67M
  • 10 Day Average Volume0.61M
  • Dividend-
  • Dividend Yield-
  • Beta1.12
  • YTD % Change-14.89

KEY STATS

  • Open13.70
  • Day High14.09
  • Day Low13.62
  • Prev Close13.68
  • 52 Week High21.22
  • 52 Week High Date12/22/23
  • 52 Week Low11.03
  • 52 Week Low Date10/04/23
  • Market Cap1.758B
  • Shares Out127.67M
  • 10 Day Average Volume0.61M
  • Dividend-
  • Dividend Yield-
  • Beta1.12
  • YTD % Change-14.89

RATIOS/PROFITABILITY

  • EPS (TTM)-0.70
  • P/E (TTM)-19.63
  • Fwd P/E (NTM)-625.91
  • EBITDA (TTM)-21.791M
  • ROE (TTM)-9.07%
  • Revenue (TTM)591.643M
  • Gross Margin (TTM)41.34%
  • Net Margin (TTM)-14.87%
  • Debt To Equity (MRQ)57.16%

EVENTS

  • Earnings Date04/30/2024
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Neogenomics Inc

 

Content From Our Affiliates

Profile

MORE
NeoGenomics, Inc. provides a range of oncology diagnostic testing and consultative services which includes technical laboratory services. The Company offers professional interpretation of laboratory test results by licensed physicians who specialize in pathology and oncology. Its segments include Clinical Services and Advanced Diagnostics. The Clinical Services segment consists of clinical cancer testing; interpretation and consultative services; molecular and NGS testing...
Lynn Tetrault J.D.
Independent Chairman of the Board
Christopher Smith
Chief Executive Officer, Director
Jeffrey Sherman
Chief Financial Officer
Cynthia Dieter
Chief Accounting Officer, Controller
Shashikant Kulkarni
Executive Vice President of Research and Development, Chief Scientific Officer
Alicia Olivo
General Counsel, Company Secretary
Address
9490 Neogenomics Way
Fort Myers, FL
33912
United States

Top Peers

SYMBOLLASTCHG%CHG
AZTA
Azenta Inc
50.49-0.68-1.33%
OPK
OPKO Health Inc
1.23-0.02-1.60%
CERT
Certara Inc
16.21-0.74-4.37%
FLGT
Fulgent Genetics Inc
20.11+0.02+0.10%
NOTV
Inotiv Inc
4.70-0.72-13.28%